Compare Novo Nordisk A/S (NVO) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Sezzle Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Sezzle Inc trades at $179.07 (market cap $5.78B). The key difference: Novo Nordisk A/S is far larger — about 38.2× Sezzle Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals.
| NVO | SEZL | |
|---|---|---|
Market Cap | $220.53B | $5.78B |
Sector | Health | Technology |
52-Week High | $71.70 | $188.55 |
52-Week Low | $35.29 | $50.97 |
Enterprise Value | $239.49B | $5.80B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
